REFERENCES
- Wolfe F, Ross K, Anderson J, Russell I J, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19–28
- Wilke W S. Treatment of “resistant” fibromyalgia. Rheum Dis Clin NA 1995; 21: 247–260
- Simms R W. Controlled trials of therapy in fibromyalgia syndrome. Bailliere's Clin Rheum 1994; 8: 917–934
- Wagstaff A J, Byson H M. Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs 1997; 53: 435–452
- Nabeshima T, Matsuno K, Sugimoto A, Kameyama T. Antinociceptive activity induced by tizanidine and alpha2-adrenoreceptors. Neuropharmacology 1987; 26: 1453–1455
- Asano T, Dohi S, Ohta S, Shimonaka H, Iida H. Antinociception by epidural and systemic alpha[2]-adrenoceptor agonists and their binding affinity in rat spinal cord and brain. Anesth Analg 2000; 90: 400–407
- Kawamata T, Omote K, Kawamata M, Iwasaki H, Namiki A. Antinociceptive interaction of intrathecal alpha2-adrenergic agonists, tizanidine and clonidine, with lidocaine in rats. Anesthesiology 1997; 87: 436–48
- Ono N, Kroin J S, Penn R D, Paice J A. Effects of intrathecal nonnarcotic analgesics on chronic tactile allodynia in rats: Alpha 2-agonists versus somatostatin analog. Neurol Med Chir [Tokyo] 1997; 37: 6–10
- Kroin J S, McCarthy R J, Penn R D, Lubenow T R, Ivankovich A D. Intrathecal clonidine and tizanidine in conscious dogs: Comparison of analgesic and hemodynamic effects. Anesth Analg 1996; 82: 627–635
- Garcia-Rosas R, Escobedo Bribo V. National multicenter study of the efficacy and tolerability of tizanidine in the management of painful muscle spasms. J Int Med Res 1993; 19: S166–S175
- Lee H K, Jahng J S, Kang E S. The Korean Painful Spasm Group. A multicentre study to evaluate the efficacy and tolerability of tizanidine in the treatment of acute painful muscle spasms in Korea. Br J Clin Res 1990; 1: 23–32
- Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbraun A S, Masi A T, Mc Cain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 160–172
- Burckhardt C S, Clark S R, Bennett R M. The Fibromyalgia Impact Questionnaire: Development and Validation. J Rheumatology 1991; 18: 728–733
- Koyuncuoglu H, Kara I, Gunel M A, Nurten A, Yamanturk P. N-methyl-D-aspartate antagonists, glutamate release inhibitors, 4-aminopyridine at neuromuscular transmission. Pharmacol Res 1998; 37: 485–491
- Miettinen T J, Kanto J H, Salonen M A, Scheinin M. The sedative and sympatholytic effects of oral tizanidine in healthy volunteers. Anesth Analg 1996; 82: 817–20
- McCain G A. Fibromyalgia and myofascial pain syndromes. Textbook of Pain, 3rd ed., P D Wall, R Melzack. Churchill Livingstone;, Edinburgh 1994; 475–493
- Pillemer S R, Bradley L A, Crofford L J, Moldofsky Chrousos GP. The neuroscience and endocrinology of fibromyalgia. Arthriris Rheum 1997; 40: 1928–1939
- Bennett R M, Cook D M, Clark S R, Burckhardt C S, Campbell S M. Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol 1997; 24: 1384–1389